FBC
MDXG icon

Fairfield, Bush & Co’s MiMedx Group MDXG Stock Holding History

Fairfield, Bush & Co’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-7,652
Closed -$67.1K – 325
2023
Q4 		$67.1K Buy
+7,652
New +$56K 0.04% 179
2023
Q3 		– Sell
-7,652
Closed -$50.6K – 342
2023
Q2 		$50.6K Buy
+7,652
New +$39K 0.01% 226
2022
Q3 		– Sell
-7,700
Closed -$27K – 314
2022
Q2 		$27K Buy
+7,700
New +$30.2K 0.02% 236
2022
Q1 		– Sell
-15,800
Closed -$95K – 130
2021
Q4 		$95K Sell
15,800
-3,000
-16% -$20.8K 0.05% 130
2021
Q3 		$114K Buy
+18,800
New +$212K 0.04% 157
2013
Q4 		– Sell
-6,300
Closed -$26K – 200
2013
Q3 		$26K Hold
6,300
– – 0.01% 216
2013
Q2 		$44K Buy
+6,300
New +$44K 0.02% 185

Other funds holding MDXG

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fairfield, Bush & Co's MDXG Position: Q1 2024 in Review

Fairfield, Bush & Co sold out of MiMedx Group (MDXG) in Q1 2024, closing a stake of 7,652 shares — an estimated $67.1K sold.

Fairfield, Bush & Co first reported a position in MDXG in Q2 2013 and held it in 7 quarters. The position peaked at $114K in Q3 2021. 202 funds tracked by Wall St. Rank hold MDXG as of Q1 2024.

  • Fairfield, Bush & Co reported no remaining MiMedx Group position as of Q1 2024 after selling out during the quarter.
  • Fairfield, Bush & Co sold 7,652 MiMedx Group shares in Q1 2024, an estimated $67.1K.
  • Fairfield, Bush & Co first reported a position in MiMedx Group in Q2 2013 and held it in 7 quarters.
  • Fairfield, Bush & Co's MiMedx Group position peaked at $114K in Q3 2021.
  • 202 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2024.

Based on Fairfield, Bush & Co's 13F filing for Q1 2024, filed 15 May 2024.